TMCI Q3 2024 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena

TMCITreace Medical Concepts, Inc.

$104M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$45M+10.6% YoY

Gross Profit

$36M80.1% margin

Operating Income

-$15M-33.6% margin

Net Income

-$15M-34.1% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$15M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$213M

Total Liabilities

$108M

Stockholders' Equity

$105M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$41M	+10.6%
Gross Profit	$36M	$33M	+10.3%
Operating Income	-$15M	-$18M	+15.1%
Net Income	-$15M	-$18M	+12.3%